Published in J Pathol on August 01, 1977
A morphological assessment of the stimulatory effect of coumarin on macrophages. Br J Exp Pathol (1978) 0.92
Coumarin or warfarin treatment of mice does not increase the microbicidal or tumoricidal capacities of macrophages. Br J Exp Pathol (1981) 0.81
Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis. Br J Cancer (1980) 0.78
Professor Derek Albert Willoughby (1930-2004). Inflammopharmacology (2005) 0.75
Resolution rates of artificially produced protein and amino acid oedemas and the effects of a benzopyrone. Br J Exp Pathol (1981) 0.75
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med (1999) 6.91
The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol (1981) 3.99
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature (1990) 3.81
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Possible new role for NF-kappaB in the resolution of inflammation. Nat Med (2001) 3.53
Apatite deposition disease. A new arthropathy. Lancet (1976) 3.53
The origin of the mononuclear cells in inflammatory exudates induced by fibrinogen. J Pathol Bacteriol (1965) 3.34
Screens for anti-inflammatory drugs. J Pharm Pharmacol (1971) 3.24
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A (1994) 3.20
Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med (1996) 3.12
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Complement in acute inflammation. J Pathol (1969) 2.20
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
Increased inflammatory reactivity in newly formed lining tissue. J Pathol (1983) 2.01
Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab Invest (1993) 1.80
Synovial fluid crystals. Q J Med (1979) 1.77
Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest (1992) 1.69
Macrophage proliferation in vitro induced by exudates. Nature (1975) 1.55
The identification of particulate matter in biological tissues and fluids. J Pathol (1977) 1.54
Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis (1982) 1.49
Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol (1983) 1.47
The origin of mononuclear cells in chronic inflammation and tuberculin reactions in the rat. J Pathol Bacteriol (1968) 1.47
Induction of DNA synthesis in rat macrophages in vitro by inflammatory exudate. Nature (1975) 1.45
Distribution of prostaglandins in inflammatory exudate. J Pathol (1973) 1.45
Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents. J Med Chem (1993) 1.45
Possible pharmacological mediators of delayed hypersensitivity. Br Med Bull (1967) 1.43
Lymph node permeability factor in the dinitrochlorobenzene skin hypersensitivity reaction in guinea-pigs. Immunology (1965) 1.42
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. Agents Actions (1989) 1.42
Direct degradation of articular cartilage by rheumatoid synovial fluid: contribution of proteolytic enzymes. J Rheumatol (1994) 1.41
Evidence for an endogenous antigen in the adjuvant arthritic rat. J Pathol (1973) 1.40
Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol (1994) 1.40
Mixed crystal deposition disease and osteoarthritis. Br Med J (1978) 1.39
Pertussis vaccine pleurisy: a model of delayed hypersensitivity. Agents Actions (1976) 1.37
Relationships between inhibition of rat polymorphonuclear chemotaxis and various inflammatory reactions. Agents Actions (1979) 1.36
Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol (1997) 1.32
A quantitative study of leucocyte emigration in chronic inflammatory granulomata. J Pathol Bacteriol (1967) 1.32
Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs. J Pathol (1975) 1.30
Oxytricha telomeric nucleoprotein complexes reconstituted with synthetic DNA. Nucleic Acids Res (1989) 1.27
Pioglitazone. Drugs (2000) 1.27
Mediators of the inflammatory response and their modification by therapeutic agents. Proc R Soc Med (1967) 1.25
Legionella pneumophila serogroup 9: a cause of human pneumonia. Ann Intern Med (1984) 1.23
Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro. Immunology (1976) 1.19
The interrelations of complement and a prostaglandin-like substance in acute inflammation. J Pathol (1970) 1.18
Calcium pyrophosphate-induced pleurisy in rats: a new model of acute inflammation. Agents Actions (1975) 1.18
Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs. Agents Actions (1976) 1.17
Further studies on carrageenan-induced pleurisy in rats. J Pathol (1975) 1.17
The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther (1995) 1.16
Effects of prostaglandins PGF2a and PGE1 on vascular permeability. J Pathol Bacteriol (1968) 1.15
Evaluation of multiphase implants for repair of focal osteochondral defects in goats. Biomaterials (2000) 1.13
Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy. Ann Rheum Dis (1975) 1.13
Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin. Arthritis Rheum (1990) 1.12
Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann Rheum Dis (1986) 1.12
Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol (1998) 1.12
Some scanning electron-microscope observations on stimulated lymphocytes. J Pathol (1971) 1.12
Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br J Exp Pathol (1985) 1.10
Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol (2001) 1.10
Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res (1998) 1.09
The role of polymorphonuclear leucocytes in acute inflammation in agranulocytic rats. J Pathol (1969) 1.08
Connective tissue abnormalities in MRL/1 mice. Ann Rheum Dis (1986) 1.08
The use of the air pouch to study experimental synovitis and cartilage breakdown. Biomed Pharmacother (1986) 1.07
Studies on the mechanism of cartilage degradation. J Pathol (1984) 1.07
Membrane properties and esterase activity of synovial lining cells: further evidence for a mononuclear phagocyte subpopulation. Ann Rheum Dis (1982) 1.06
A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J Biomed Mater Res (1996) 1.06
An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation. Antibiot Chemother (1969) 1.06
Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci (1993) 1.05
Measurement of inflammation. I. Application of technetium clearance to rheumatoid arthritis and animal models. Ann Rheum Dis (1973) 1.05
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs (2001) 1.04
An analysis of the irritant action of dimethyl sulphoxide. J Pathol Bacteriol (1966) 1.04
The effect of parathyroid hormone, 1,25-dihydroxycholecalciferol and prostaglandins on the cytoplasmic activity of isolated osteoclasts. J Pathol (1982) 1.03
The mechanism of cutaneous hypersensitivity in the rat and its suppression by immunological methods. J Pathol Bacteriol (1966) 1.03
Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Sci (Lond) (1989) 1.03
A model for the quantitative study of Arthus (immunologic) hypersensitivity in rats. Agents Actions (1975) 1.02
Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience (1994) 1.02
Inflammation in agranulocytotic rats. Nature (1968) 1.02
Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther (1994) 1.01
Effect of the selective leukotriene B4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am Rev Respir Dis (1989) 1.00
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann Rheum Dis (1993) 1.00
The role of cAMP regulation in controlling inflammation. Clin Exp Immunol (1995) 1.00
Bone marrow and lymph node cells in the rejection of skin allografts in mice. Immunology (1970) 0.99
Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis. Cell Immunol (1989) 0.99
Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur J Pharmacol (1998) 0.98